Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jon Warkentin"'
Autor:
John James Parker, Rany Octaria, Miranda D. Smith, Samantha J. Chao, Mary Beth Davis, Celia Goodson, Jon Warkentin, Denise Werner, Mary-Margaret A. Fill
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 10, Pp 2521-2528 (2021)
As of March 2021, coronavirus disease (COVID-19) had led to >500,000 deaths in the United States, and the state of Tennessee had the fifth highest number of cases per capita. We reviewed the Tennessee Department of Health COVID-19 surveillance and ch
Externí odkaz:
https://doaj.org/article/7d4207144b4a4e40a31f14a0e83b3672
Autor:
Adoma Manful, Leslie Waller, Ben Katz, Jason Cummins, Jon Warkentin, Billy Reagon, Joanna Shaw-Kaikai, Yuwei Zhu, Yuri F. van der Heijden
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Treatment of tuberculosis infection (TBI) in individuals at high risk for tuberculosis (TB) disease is a priority for TB elimination in the US. Newly arrived refugees in Middle Tennessee are screened for TBI, but factors associate
Externí odkaz:
https://doaj.org/article/b5142a6a99224116be3ec471be051b49
Autor:
Samuel Parks, Neha Shah, Barbara Seaworth, Felicia Dworkin, Terence Chorba, Jon Warkentin, Sundari Mase, Ann Belanger, Pennan M. Barry
Publikováno v:
Clin Infect Dis
Background In 2012, the Food and Drug Administration approved use of bedaquiline fumarate as part of combination therapy for multidrug-resistant tuberculosis (MDR TB). We describe treatment outcomes, safety, and tolerability of bedaquiline in our cas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93aeee071044d665f689fa985bc6945a
https://pubmed.ncbi.nlm.nih.gov/31556947
https://pubmed.ncbi.nlm.nih.gov/31556947
Autor:
Y. F. van der Heijden, Jon Warkentin, Timothy R. Sterling, Ed Mitchel, Fernanda Maruri, Erin Holt
Publikováno v:
Epidemiology and Infection. 143:960-965
Fluoroquinolone use before tuberculosis diagnosis delays the time to diagnosis and treatment, and increases the risk of fluoroquinolone-resistant tuberculosis and death. Ascertainment of fluoroquinolone exposure could identify such high-risk patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88a1f808dd2e96063605c3cb709f36c8
https://doi.org/10.1017/s0950268814003136
https://doi.org/10.1017/s0950268814003136
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 17:486-492
TUBERCULOSIS (TB) remains an important public health problem in the United States. The development of effective treatment has led to a dramatic reduction in TB disease. However, failure to complete treatment in a timely manner leads to a potentially
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9cb48c04830ee75b29ad8fe9b33e4f3
https://doi.org/10.5588/ijtld.12.0133
https://doi.org/10.5588/ijtld.12.0133
Autor:
Bryan E. Shepherd, Jon Warkentin, Y. F. van der Heijden, Erin Holt, Timothy R. Sterling, Amondrea Blackman, Fernanda Maruri
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 16:1162-1167
Despite a Decrease in worldwide incidence since 2002, tuberculosis (TB) continues to be a major cause of mortality worldwide; it is estimated that 1.45 million persons died from TB in 2010.1 Factors that increase the risk of TB-associated death inclu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef28c14e497f31534b85133b13650915
https://doi.org/10.5588/ijtld.12.0046
https://doi.org/10.5588/ijtld.12.0046
Autor:
April C. Pettit, Fernanda Maruri, Teresa Smith, J. Cummins, Marie R. Griffin, Lisa A. Kaltenbach, Timothy R. Sterling, Jon Warkentin
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 15:906-911
Recurrent tuberculosis (TB) is due to exogenous re-infection with a new Mycobacterium tuberculosis strain or relapse with the initial strain. Genotyping can distinguish between genotypically identical (relapse) and dissimilar (re-infection) strains.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a67bab2834a62792a0a0676f14c2b68b
https://doi.org/10.5588/ijtld.10.0448
https://doi.org/10.5588/ijtld.10.0448
Autor:
Stephen Hawkins, Maryam B. Haddad, Brenda Ali, Sarah Stuart Chewning, Lauren A. Lambert, Erin Holt, Rachel Allen, Valerie Boaz, Margaret Zylstra, Sheliah Rivers, Jon Warkentin, Roque Miramontes
Publikováno v:
Southern Medical Journal. 103:882-886
In June 2007, the Tennessee Department of Health notified the Centers for Disease Control and Prevention of four multidrug-resistant tuberculosis (MDR TB) cases in individuals of Guatemalan descent, and requested onsite epidemiologic assistance to in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::948a1d951db762a95f9d29a3df0979d8
https://doi.org/10.1097/smj.0b013e3181eba488
https://doi.org/10.1097/smj.0b013e3181eba488
Autor:
Moises A. Huaman, Timothy F. Jones, Fernanda Maruri, Jon Warkentin, Christina T. Fiske, L. A. Ingram, Bryan E. Shepherd, Timothy R. Sterling
SUMMARYPersons who develop tuberculosis (TB) may have subtle immune defects that could predispose to other intracellular bacterial infections (ICBIs). We obtained data on TB and five ICBIs (Chlamydia trachomatis, Salmonellaspp.,Shigellaspp.,Yersinias
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f7040d6dc967f9d96f77a3ebef2e05e
https://europepmc.org/articles/PMC4336842/
https://europepmc.org/articles/PMC4336842/
Autor:
Jon Warkentin, Fernanda Maruri, Svetlana K. Eden, Ed Mitchel, Timothy R. Sterling, Aihua Bian, Yuri F. van der Heijden, Ayumi Shintani, Amondrea Blackman
Fluoroquinolone exposure before tuberculosis (TB) diagnosis is common. We anticipated that exposure to older-generation fluoroquinolones is associated with greater fluoroquinolone MICs in Mycobacterium tuberculosis than exposure to newer agents. A ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48831d0922248e47f6574b70a66a09fd
https://europepmc.org/articles/PMC3780576/
https://europepmc.org/articles/PMC3780576/